CAS 2356152-56-0

Formula: C14H17Br2ClN2O

InChI: InChI=1S/C14H16Br2N2O.ClH/c15-10-5-9-7-18(8-17-14(9)13(16)6-10)11-1-3-12(19)4-2-11;/h5-6,8,11-12,19H,1-4,7H2;1H

InChI key: FFENEVSGUVRJMN-UHFFFAOYSA-N

SMILES: C1CC(CCC1N2CC3=C(C(=CC(=C3)Br)Br)N=C2)O.Cl

trans-4-(6,8-Dibromoquinazolin-3(4H)-yl)cyclohexanol Hydrochloride

Controlled Product

CAS: 2356152-56-0

Formula: C₁₄H₁₆Br₂N₂O·ClH

Color and Shape: Neat

Molecular weight: 424.56

Ref: 86-MM0005.11

6,8-Dibrom-3-trans-4-hydroxycyclohexyl-3,4-dihydroquinazoline Hydrochloride

CAS: 2356152-56-0

Formula: C₁₄H₁₆Br₂N₂OHCl

Molecular weight: 388.10 : 36.46

Ref: ST-EA-CP-A38024

trans-4-(6,8-Dibromo-3(4H)-quinazolinyl)cyclohexanol hydrochloride

CAS: 2356152-56-0

Trans-4-(6,8-Dibromo-3(4H)-quinazolinyl)cyclohexanol hydrochloride is a potent kinase inhibitor that has shown promising results in anticancer research. It specifically targets human kinases and induces apoptosis in cancer cells. This compound has been identified as a potential therapeutic agent for the treatment of various types of tumors, including those found in breast, lung, and prostate cancers. In addition to its medicinal properties, trans-4-(6,8-Dibromo-3(4H)-quinazolinyl)cyclohexanol hydrochloride can be detected in urine samples and serves as an important tool for researchers studying protein kinases and their inhibitors. This analog of Chinese medicine is a valuable addition to any laboratory seeking to advance cancer research through the development of new therapies.

Formula: C₁₄H₁₆Br₂N₂O•HCl

Purity: Min. 95%

Molecular weight: 424.56 g/mol

Ref: 3D-ID183211